Market Closed -
Nasdaq
04:00:00 2024-07-11 pm EDT
|
5-day change
|
1st Jan Change
|
50.43
USD
|
+1.14%
|
|
+2.81%
|
+6.48%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
2,940
|
3,499
|
3,000
|
2,645
|
3,186
|
3,358
|
-
|
-
|
Enterprise Value (EV)
1 |
4,382
|
5,028
|
4,944
|
4,809
|
5,741
|
5,380
|
5,146
|
5,072
|
P/E ratio
|
38.2
x
|
-22.3
x
|
-
|
-
|
-
|
-
|
20.4
x
|
-
|
Yield
|
3.65%
|
1.03%
|
0.82%
|
1.64%
|
1.54%
|
1.49%
|
1.53%
|
1.61%
|
Capitalization / Revenue
|
1.06
x
|
1.32
x
|
0.68
x
|
0.61
x
|
0.86
x
|
0.88
x
|
0.82
x
|
0.84
x
|
EV / Revenue
|
1.57
x
|
1.9
x
|
1.12
x
|
1.12
x
|
1.54
x
|
1.41
x
|
1.26
x
|
1.27
x
|
EV / EBITDA
|
7.74
x
|
14.5
x
|
4.46
x
|
5.16
x
|
9.23
x
|
7.76
x
|
5.89
x
|
5.37
x
|
EV / FCF
|
22.9
x
|
42.2
x
|
6.6
x
|
12
x
|
27.1
x
|
13.3
x
|
9.48
x
|
7.27
x
|
FCF Yield
|
4.37%
|
2.37%
|
15.1%
|
8.33%
|
3.69%
|
7.5%
|
10.5%
|
13.7%
|
Price to Book
|
2.21
x
|
3.05
x
|
1.76
x
|
1.12
x
|
1.48
x
|
1.61
x
|
1.55
x
|
1.63
x
|
Nbr of stocks (in thousands)
|
76,196
|
76,196
|
75,811
|
69,974
|
67,377
|
67,387
|
-
|
-
|
Reference price
2 |
38.58
|
45.92
|
39.58
|
37.80
|
47.28
|
49.84
|
49.84
|
49.84
|
Announcement Date
|
1/29/20
|
1/27/21
|
1/26/22
|
2/2/23
|
1/31/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
2,784
|
2,650
|
4,415
|
4,311
|
3,723
|
3,821
|
4,080
|
3,986
|
EBITDA
1 |
566
|
346
|
1,108
|
932
|
622
|
693.2
|
873.7
|
944.2
|
EBIT
1 |
221.9
|
-11.13
|
745
|
560
|
230
|
426.4
|
552
|
414.1
|
Operating Margin
|
7.97%
|
-0.42%
|
16.87%
|
12.99%
|
6.18%
|
11.16%
|
13.53%
|
10.39%
|
Earnings before Tax (EBT)
1 |
120.8
|
-187.4
|
666.3
|
582.1
|
285.6
|
221
|
247
|
-
|
Net income
1 |
88
|
-157
|
482
|
353.8
|
174.1
|
133.7
|
215.7
|
-
|
Net margin
|
3.16%
|
-5.92%
|
10.92%
|
8.21%
|
4.68%
|
3.5%
|
5.29%
|
-
|
EPS
|
1.010
|
-2.060
|
-
|
-
|
-
|
-
|
2.440
|
-
|
Free Cash Flow
1 |
191.6
|
119.3
|
748.5
|
400.4
|
211.8
|
403.3
|
542.9
|
697.3
|
FCF margin
|
6.88%
|
4.5%
|
16.95%
|
9.29%
|
5.69%
|
10.55%
|
13.31%
|
17.49%
|
FCF Conversion (EBITDA)
|
33.85%
|
34.47%
|
67.55%
|
42.96%
|
34.05%
|
58.18%
|
62.14%
|
73.85%
|
FCF Conversion (Net income)
|
217.69%
|
-
|
155.29%
|
113.16%
|
121.64%
|
301.71%
|
251.72%
|
-
|
Dividend per Share
2 |
1.410
|
0.4725
|
0.3250
|
0.6200
|
0.7300
|
0.7428
|
0.7642
|
0.8024
|
Announcement Date
|
1/29/20
|
1/27/21
|
1/26/22
|
2/2/23
|
1/31/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
1,253
|
1,176
|
1,137
|
1,012
|
986.1
|
1,038
|
939.4
|
823
|
922.4
|
916
|
956.3
|
888.9
|
977.1
|
1,061
|
996
|
EBITDA
1 |
340
|
337
|
243
|
192
|
160
|
209
|
160
|
105
|
148
|
160
|
170.5
|
168
|
196.1
|
223.9
|
221.5
|
EBIT
1 |
253
|
245
|
149
|
91.98
|
74
|
111
|
64.54
|
6.715
|
48
|
65
|
59.1
|
53.27
|
113.3
|
147.5
|
128.8
|
Operating Margin
|
20.19%
|
20.84%
|
13.1%
|
9.09%
|
7.5%
|
10.69%
|
6.87%
|
0.82%
|
5.2%
|
7.1%
|
6.18%
|
5.99%
|
11.6%
|
13.91%
|
12.93%
|
Earnings before Tax (EBT)
1 |
242.9
|
178.9
|
175.9
|
161.8
|
65.56
|
104.4
|
110
|
26.09
|
45.13
|
72.09
|
50
|
48
|
51
|
67
|
61
|
Net income
1 |
201
|
118.5
|
125.1
|
69.2
|
41.03
|
59.77
|
56.69
|
24
|
33.49
|
53
|
22
|
18.5
|
18
|
44
|
40
|
Net margin
|
16.04%
|
10.08%
|
11%
|
6.84%
|
4.16%
|
5.76%
|
6.03%
|
2.92%
|
3.63%
|
5.79%
|
2.3%
|
2.08%
|
1.84%
|
4.15%
|
4.02%
|
EPS
2 |
-
|
1.600
|
1.410
|
0.8700
|
0.5900
|
0.8700
|
0.7300
|
0.3600
|
0.5000
|
0.7700
|
0.3600
|
0.3400
|
0.3700
|
0.6600
|
0.6000
|
Dividend per Share
2 |
0.1250
|
0.1250
|
0.1450
|
0.1750
|
0.1750
|
-
|
0.1850
|
0.1850
|
0.1850
|
0.1850
|
0.1882
|
0.1912
|
0.1912
|
0.1975
|
0.1968
|
Announcement Date
|
1/26/22
|
4/27/22
|
7/27/22
|
10/26/22
|
2/2/23
|
4/26/23
|
7/26/23
|
10/25/23
|
1/31/24
|
4/24/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
1,442
|
1,530
|
1,943
|
2,164
|
2,556
|
2,022
|
1,788
|
1,714
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
2.548
x
|
4.421
x
|
1.754
x
|
2.322
x
|
4.109
x
|
2.917
x
|
2.046
x
|
1.815
x
|
Free Cash Flow
1 |
192
|
119
|
748
|
400
|
212
|
403
|
543
|
697
|
ROE (net income / shareholders' equity)
|
4.99%
|
-12.6%
|
34.1%
|
16.1%
|
6.65%
|
10.2%
|
15.1%
|
11.9%
|
ROA (Net income/ Total Assets)
|
-
|
-2.88%
|
8.19%
|
-
|
-
|
3%
|
5%
|
-
|
Assets
1 |
-
|
5,457
|
5,888
|
-
|
-
|
4,456
|
4,313
|
-
|
Book Value Per Share
2 |
17.50
|
15.10
|
22.50
|
33.90
|
32.00
|
31.00
|
32.10
|
30.60
|
Cash Flow per Share
2 |
6.720
|
6.050
|
13.00
|
13.60
|
9.740
|
11.20
|
13.60
|
18.40
|
Capex
1 |
324
|
342
|
245
|
577
|
448
|
196
|
158
|
152
|
Capex / Sales
|
11.63%
|
12.9%
|
5.56%
|
13.39%
|
12.04%
|
5.14%
|
3.88%
|
3.82%
|
Announcement Date
|
1/29/20
|
1/27/21
|
1/26/22
|
2/2/23
|
1/31/24
|
-
|
-
|
-
|
Last Close Price
49.84
USD Average target price
53.5
USD Spread / Average Target +7.35% Consensus |
1st Jan change
|
Capi.
|
---|
| +2.08% | 101B | | -10.18% | 59.19B | | +82.86% | 50.62B | | +4.83% | 33.55B | | -0.97% | 30.23B | | +4.40% | 18.17B | | +20.79% | 17.33B | | +82.12% | 13.4B | | +7.97% | 13.31B |
Other Commodity Chemicals
|